These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 30054254)

  • 1. Quality standard for the management of patients with psoriatic arthritis: QUANTUM Project.
    Sanz Sanz J; Beltrán E; Díaz-Miguel Pérez MC; Fernández-Carballido C; Galíndez E; García Porrua C; Gratacós J; Medina J; Queiro R; Ramírez J; Reina D; Rodríguez Lozano C; Rodríguez Martínez FJ; Rubio E; Veroz R
    Reumatol Clin (Engl Ed); 2020; 16(3):203-215. PubMed ID: 30054254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations of the Mexican College of Rheumatology for the management of psoriatic arthritis.
    Casasola-Vargas J; Flores-Alvarado D; Silveira LH; Sicsik-Ayala S; Reyes-Cordero G; Villanueva Quintero G; Amaya Guerra M; Reyes Orozco SG; Zazueta Montiel BE; Hernández-Paz R; Mendoza-Fuentes A; Bernard-Medina AG; López Rodriguez A; Barbosa Cobos RE; Burgos-Vargas R; Pacheco-Tena C
    Reumatol Clin (Engl Ed); 2021 Dec; 17(10):611-621. PubMed ID: 34305032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and feasibility of 4 checklists for the evaluation of comorbidity in patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis: GECOAI Project.
    Castañeda S; González C; Villaverde V; Lajas Petisco C; Castro MC; Jirout F; Obaya JC; Hermosa JC; Suárez C; García S; Rodero M; León L; López Esteban A; Gobbo M; Alcaide L; Torre-Alonso JC
    Reumatol Clin (Engl Ed); 2020 Dec; ():. PubMed ID: 33293243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriatic arthritis screening: A systematic literature review and experts' recommendations.
    Urruticoechea-Arana A; Benavent D; León F; Almodovar R; Belinchón I; de la Cueva P; Fernández-Carballido C; Loza E; Gratacós J;
    PLoS One; 2021; 16(3):e0248571. PubMed ID: 33720981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoting patient-centred care in psoriatic arthritis: a multidisciplinary European perspective on improving the patient experience.
    Betteridge N; Boehncke WH; Bundy C; Gossec L; Gratacós J; Augustin M
    J Eur Acad Dermatol Venereol; 2016 Apr; 30(4):576-85. PubMed ID: 26377041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevating the Standard of Care for Patients with Psoriatic Arthritis: 'Calls to Action' from a Multistakeholder Pan-European Initiative.
    Verbinnen I; Monte-Boquet E; Parow D; Lacombe F; Pothecary A; van Kuijk AWR; Harrington L; Müllerová E; Pinter A; Erstling U; Tomasini A; Helliwell PS
    Rheumatol Ther; 2024 Jun; 11(3):795-815. PubMed ID: 38662145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations of the Mexican College of Rheumatology for the management of psoriatic arthritis.
    Casasola-Vargas J; Flores-Alvarado D; Silveira LH; Sicsik-Ayala S; Reyes-Cordero G; Villanueva Quintero G; Amaya Guerra M; Reyes Orozco SG; Zazueta Montiel BE; Hernández-Paz R; Mendoza-Fuentes A; Bernard-Medina AG; López Rodriguez A; Barbosa Cobos RE; Burgos-Vargas R; Pacheco-Tena C
    Reumatol Clin (Engl Ed); 2021 Apr; ():. PubMed ID: 33931333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in Diagnosing Psoriatic Arthritis in Primary Care: A Meta-Ethnographic Study.
    Ohta R; Sano C
    Cureus; 2023 Nov; 15(11):e49443. PubMed ID: 38149126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthetic indicator of compliance with standards for Quality Units of health centers and multicenter prospective pilot study].
    Aloy-Duch A; Santiñà Vila M; Ramos-d'Angelo F; Alonso Calo L; Llaneza-Velasco ME; Fortuny-Organs B; Apezetxea-Celaya A
    J Healthc Qual Res; 2024; 39(4):214-223. PubMed ID: 38594160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualifying unmet needs and improving standards of care in psoriatic arthritis.
    Helliwell P; Coates L; Chandran V; Gladman D; de Wit M; FitzGerald O; Kavanaugh A; Strand V; Mease PJ; Boehncke WH; Langley RG; Lubrano E; Maccarone M; Schulze-Koops H; Miceli-Richard C; Queiro R
    Arthritis Care Res (Hoboken); 2014 Dec; 66(12):1759-66. PubMed ID: 25047391
    [No Abstract]   [Full Text] [Related]  

  • 11. Quality Certification Standard Proposal "SpACE" for Axial Spondyloarthritis Treatment Units.
    García EI; Martin-Delgado J; Queiro R; Pérez Venegas JJ; Gratacos J; Sanz J; Torrés A; Mira JJ;
    Reumatol Clin (Engl Ed); 2021 Jun; ():. PubMed ID: 34148827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and Risk of Inflammatory Bowel Disease in Patients with Psoriasis-A Nationwide 20-Year Cohort Study.
    Egeberg A; Thyssen JP; Burisch J; Colombel JF
    J Invest Dermatol; 2019 Feb; 139(2):316-323. PubMed ID: 30130618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The History of Psoriatic Arthritis (PsA): From Moll and Wright to Pathway-Specific Therapy.
    Espinoza LR
    Curr Rheumatol Rep; 2018 Aug; 20(10):58. PubMed ID: 30094476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings.
    Iannone F; Salaffi F; Fornaro M; Di Carlo M; Gentileschi S; Cantarini L; Lopalco G
    Eur J Clin Invest; 2018 Nov; 48(11):e13013. PubMed ID: 30079593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register.
    Fagerli KM; Kearsley-Fleet L; Mercer LK; Watson K; Packham J; Symmons DPM; Hyrich KL
    Rheumatology (Oxford); 2019 Jan; 58(1):80-85. PubMed ID: 30137485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiologic approach to axial spondyloarthritis: where are we now and where are we heading?
    Kucybała I; Urbanik A; Wojciechowski W
    Rheumatol Int; 2018 Oct; 38(10):1753-1762. PubMed ID: 30132215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms Underlying the Clinical Effects of Apremilast for Psoriasis.
    Pincelli C; Schafer PH; French LE; Augustin M; Krueger JG
    J Drugs Dermatol; 2018 Aug; 17(8):835-840. PubMed ID: 30124722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enthesitis and Dactylitis in Psoriatic Disease: A Guide for Dermatologists.
    Bagel J; Schwartzman S
    Am J Clin Dermatol; 2018 Dec; 19(6):839-852. PubMed ID: 30117018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of disease-modifying anti-rheumatic or anti-tumour necrosis factor drugs and risk of hospitalized infection in ankylosing spondylitis.
    Moura CS; Rahme E; Maksymowych WP; Abrahamowicz M; Bessette L; Bernatsky S
    Scand J Rheumatol; 2019 Mar; 48(2):121-127. PubMed ID: 30112959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis.
    Blauvelt A; Chiricozzi A
    Clin Rev Allergy Immunol; 2018 Dec; 55(3):379-390. PubMed ID: 30109481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.